Parabilis Medicines Net Income

As of the most recent data (June 2026), PBLS shows a net income of $-170M. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.

The Healthcare sector average net income is about $16B. Parabilis Medicines is at $-170M, which is lower that average. That is roughly 101.1% below the sector mean. Use the comparison chart on this page to see how PBLS stacks up against individual peers as well.

Tracking PBLS's net income over time shows whether Parabilis Medicines is scaling, shrinking, or reshaping that part of the business. The current reading is $-170M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has Parabilis Medicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-170M) with ownership activity and broader fundamentals.

The Healthcare average net income is about $16B, while PBLS is at $-170M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.